vickyhkapi, Author at HKAPI

13 Feb 23

Briefing session for Regulatory Intelligence Survey

The Hong Kong Association of Pharmaceutical Industry organized a successful briefing session for its Regulatory Intelligence Survey, attracting over 50 members to join the event.

11 Jan 23

Code of Practice Train-the-Trainer Workshop 2023

More than 260 members attended the Code of Practice Train-the-Trainer Workshop on 11 January 2023 to understand the key changes of the Code and its implications for HKAPI members.

09 Jan 23

Appointment of New Board Member

We are pleased to announce that Mr. Derek Chang has been elected as a Board Member of the association to fill the vacancy in the Board with effect from 9th January 2023.

January 9, 2023
vickyhkapi
No Comments

The DH met virtually with pharmaceutical associations to discuss a series of measures to maintain the steady supply of medicines.

11 Nov 22

Asia Summit on Global Health 2022

Asia Summit on Global Health 2022 It is a great privilege for The Hong Kong Association of the Pharmaceutical Industry to join the Asia Summit on Global Health 2022 organized […]

07 Oct 22

Extraordinary General Meeting 2022

An online EGM was called by the HKAPI Board to pass a resolution to adopt the new Code of Practice. It was unanimously adopted by members with immediate effect.

06 Sep 22

Appointment of New Board Member

HKAPI is pleased to announce that Mr. Howard Lin has been elected as a Board Member of the association to fill the vacancy in the Board with effect from 6th September 2022.

11 Jul 22

1st CEO Meeting 2022-2024

The 1st CEO Meeting of the Term (2022-24) was held online on 11 July 2022. More than 20 CEOs and directors from our member companies joined to meet the new HKAPI Board, and exchanged views on the future directions of the Association.

June 28, 2022
vickyhkapi
No Comments

To ensure members have a thorough understanding of the relevant laws, regulations and Codes regarding medicinal material communicating to the public via different mediums, the HKAPI organises an event with law enforcement authorities and experts to explain the law and its enforcement.

02 Jun 22

Tackling the Threat of Antimicrobial Resistance

The High-Level Steering Committee on Antimicrobial Resistance was set up in 2016 to call for collaboration, synergy and cross-fertilisation of all professional sectors under the "One Health" framework in response to AMR. Ms. Sabrina Chan, the Senior Executive Director of HKAPI has been a member of the Steering Committee since the establishment of the Committee.

Briefing session for Regulatory Intelligence Survey

Code of Practice Train-the-Trainer Workshop 2023

Appointment of New Board Member

DH met with HKAPI on maintaining steady supply of paracetamol

Asia Summit on Global Health 2022

Extraordinary General Meeting 2022

Appointment of New Board Member

1st CEO Meeting 2022-2024

Pharmaceutical Promotion: UMAO & related laws and regulations

Tackling the Threat of Antimicrobial Resistance

© The Hong Kong Association of the Pharmaceutical Industry | 香港科研製藥聯會

All Right Reserved

Disclaimer

Privacy

Terms of Use